Beat the Market the Zacks Way: Oracle, American Healthcare, Palantir in Focus

Zacks11-25

The three most widely followed benchmark indexes closed the last week with gains. The S&P 500, the Nasdaq Composite and the Dow Jones Industrial Average advanced 1.7%, 1.7% and 2%, respectively. While...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2486538038?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/4UImlos11YVRz_bPus7vxg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/44deeada4a931587093cfb55cec8bf0e","is_english":true,"pubTime":"2024-11-25 21:08","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2486538038","market":"us","top_or_hot":-1,"title":"Beat the Market the Zacks Way: Oracle, American Healthcare, Palantir in Focus","media":"Zacks","content":"<div>\n<p>The three most widely followed benchmark indexes closed the last week with gains. The S&P 500, the Nasdaq Composite and the Dow Jones Industrial Average advanced 1.7%, 1.7% and 2%, respectively.\nWhile...</p>\n\n<a href=\"https://finance.yahoo.com/news/beat-market-zacks-way-oracle-130800188.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beat the Market the Zacks Way: Oracle, American Healthcare, Palantir in Focus</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeat the Market the Zacks Way: Oracle, American Healthcare, Palantir in Focus\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-25 21:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/beat-market-zacks-way-oracle-130800188.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The three most widely followed benchmark indexes closed the last week with gains. The S&P 500, the Nasdaq Composite and the Dow Jones Industrial Average advanced 1.7%, 1.7% and 2%, respectively.\nWhile...</p>\n\n<a href=\"https://finance.yahoo.com/news/beat-market-zacks-way-oracle-130800188.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B3CCJ633.GBP","symbol_name":"GUINNESS SUSTAINABLE ENERGY \"C\" (GBP) ACC","start_time":0,"source_url":"https://finance.yahoo.com/news/beat-market-zacks-way-oracle-130800188.html","article_id":"2486538038","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/4UImlos11YVRz_bPus7vxg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/44deeada4a931587093cfb55cec8bf0e"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2486538038","pubTimestamp":1732540080,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"The three most widely followed benchmark indexes closed the last week with gains. The S&P 500, the Nasdaq Composite and the Dow Jones Industrial Average advanced 1.7%, 1.7% and 2%, respectively.While there were serious apprehensions about the turn of events in the Russia-Ukraine War, trade throughout the week remained relatively upbeat on data pointing toward robust economic activity in the United States. In fact, S&P Global said late in the week that its flash U.S. Composite PMI Output Index, which tracks the manufacturing and services sectors, increased to 55.3 this month. The number is a 31-month high.However, market participants continue to weigh in on Fed officials' hawkish comments about rate cuts slowing down going forward. Despite Powell’s mid-November warning, the CME FedWatch Tool grants a 56.2% probability of a 25 basis point cut in the Fed’s December meeting.Regardless of market conditions, we, here at Zacks, provide investors with unbiased guidance on how to beat the marke","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE00B3CCJ633.GBP":"GUINNESS SUSTAINABLE ENERGY \"C\" (GBP) ACC","BK4137":"综合支持服务","BK4107":"财产与意外伤害保险","SH":"标普500反向ETF","FAST":"快扣","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","LU0096362180.USD":"CT (LUX) I GLOBAL FOCUS \"DU\" (USD)","LU1934455194.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (USD) ACC","IVV":"标普500指数ETF","LU0661504455.SGD":"Blackrock Global Equity Income A5 SGD-H","ORCL":"甲骨文","BK4225":"医疗保健房地产信托","LU0175139822.USD":"AB FCP I Global Equity Blend A USD","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","SPY":"标普500ETF","NOBL":"ProShares S&P 500 Aristocrats ETF","CORT":"Corcept医疗","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","AFG":"美国金融集团有限公司","LU1852331112.SGD":"Blackrock World Technology Fund A2 SGD-H","BK4007":"制药","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU0965509283.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (SGDHDG) INC","SSO":"两倍做多标普500ETF","UPRO":"三倍做多标普500ETF","SPXU":"三倍做空标普500ETF","VOO":"Vanguard标普500ETF","ECDP":"Eco Depot, Inc.","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","AHR":"American Healthcare REIT","FICO":"Fair Isaac Corp","OEF":"标普100指数ETF-iShares","LU0738911758.USD":"Blackrock Global Equity Income A6 USD","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC",".SPX":"S&P 500 Index","OEX":"标普100","ETN":"伊顿","VERX":"Vertex, Inc.","HD":"家得宝","SDS":"两倍做空标普500ETF","LU1429558221.USD":"Natixis Loomis Sayles US Growth Equity RA USD","GRRR":"Gorilla Technology","HCSG":"医疗保健服务","LU0444973449.USD":"CT (LUX) I GLOBAL TECHNOLOGY \"DU\" (USD) ACC","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","AXON":"Axon Enterprise, Inc.","PLTR":"Palantir Technologies Inc."},"translate_title":"以Zacks方式击败市场：甲骨文、美国医疗保健、Palantir成为焦点","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CORT":1,"HD":1,"HCSG":1,"GRRR":1,"NOBL":1,"FICO":1,"FAST":1,"ETN":1,"ECDP":1,"ORCL":1,"PLTR":1,"VERX":1,"AXON":1,"AHR":1,"AFG":1,"VOO":0.9,"SPY":0.9,"SDS":0.6,"ESmain":0.6,"OEF":0.6,"OEX":0.6,"SH":0.6,"SPXU":0.6,"SSO":0.6,"UPRO":0.6,".SPX":0.6,"IVV":0.6},"content_text":"The three most widely followed benchmark indexes closed the last week with gains. The S&P 500, the Nasdaq Composite and the Dow Jones Industrial Average advanced 1.7%, 1.7% and 2%, respectively.\nWhile there were serious apprehensions about the turn of events in the Russia-Ukraine War, trade throughout the week remained relatively upbeat on data pointing toward robust economic activity in the United States. In fact, S&P Global said late in the week that its flash U.S. Composite PMI Output Index, which tracks the manufacturing and services sectors, increased to 55.3 this month. The number is a 31-month high.\nHowever, market participants continue to weigh in on Fed officials' hawkish comments about rate cuts slowing down going forward. Despite Powell’s mid-November warning, the CME FedWatch Tool grants a 56.2% probability of a 25 basis point cut in the Fed’s December meeting.    \nRegardless of market conditions, we, here at Zacks, provide investors with unbiased guidance on how to beat the market. \nAs usual, Zacks Research guided investors over the past three months with its time-tested methodologies. Given the prevailing market uncertainty, you may want to look at our feats to prepare better for your next action.\nHere are some of our key achievements:\nGorilla Technology and American Healthcare Surge Following Zacks Rank Upgrade\nShares of Gorilla Technology Group Inc. GRRR have gained 18.9% (versus the S&P 500’s 4.5% increase) since it was upgraded to a Zacks Rank #2 (Buy) on September 26.\nAnother stock, American Healthcare REIT, Inc. AHR, which was upgraded to a Zacks Rank #1 (Strong Buy) on September 26, has returned 8.1% since then.\nZacks Rank, our short-term rating system, has earnings estimate revisions at its core. Empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. \nA hypothetical portfolio of Zacks Rank # 1 (Strong Buy) stocks returned +14% in the year-to-date period through October 7th, 2024, vs. +22.2% for the S&P 500 index and +12.4% for the equal-weight version of the S&P 500 index.\nThis hypothetical portfolio returned +20.63% in 2023 vs. +24.83% for the S&P 500 index and +15% for the equal-weight S&P 500 index.\nThe portfolio of Zacks Rank #1 stocks is an equal-weight portfolio, while the S&P 500 index is a market-cap-weighted index that has been notably distorted by the concentrated performance of mega-cap stocks since late 2022.\nThe Zacks Model Portfolio - consisting of Zacks Rank #1 stocks – has outperformed the S&P index by almost 13 percentage points since 1988 (Through October 7th, 2024, the Zacks # 1 Rank stocks generated an annualized average return of +24.1% since 1988 vs. +11.2% for the S&P 500 index).\nYou can see the complete list of today’s Zacks Rank #1 stocks here >>>\nCheck Gorilla Technology’s historical EPS and Sales here>>>\nCheck American Healthcare’s historical EPS and Sales here>>>\nImage Source: Zacks Investment Research\nZacks Recommendation Upgrades Vertex and Corcept Therapeutics\nShares of Vertex, Inc. VERX and Corcept Therapeutics Incorporated CORT have advanced 46.6% and 31% (versus the S&P 500’s 4.3% rise), respectively, since their Zacks Recommendation was upgraded to Outperform on September 30.\nWhile the Zacks Rank is our short-term rating system that is most effective over the one- to three-month holding horizon, the Zacks Recommendation aims to predict performance over the next 6 to 12 months. However, just like the Zacks Rank, the foundation for the Zacks Recommendation is trends in earnings estimate revisions.\nThe Zacks Recommendation classifies stocks into three groups — Outperform, Neutral and Underperform. While these recommendations are determined quantitatively, our analysts have the flexibility to override them for the 1100+ stocks they closely follow based on their better judgment of factors such as valuation, industry conditions and management effectiveness than the quantitative model.\nTo access our research reports with Zacks Recommendations for the 1100+ stocks we cover, click here>>>\nZacks Focus List Stocks Palantir, Axon Shoot Up\nShares of Palantir Technologies Inc. PLTR, which belongs to the Zacks Focus List, have gained 101.6% over the past 12 weeks. The stock was added to the Focus List on March 26, 2024. Another Focus-List holding, Axon Enterprise, Inc. AXON, which was added to the portfolio on June 3, 2020, has returned 70.9% over the past 12 weeks. The S&P 500 has advanced 7% over this period. \nThe Focus List portfolio returned +16.18% in 2024 (through October 31st) vs. +20.99% for the S&P 500 index and +13.29% for the equal-weight S&P 500 index.\nThe 50-stock Zacks Focus List model portfolio returned +31.44% in 2023 vs. +26.28% for the S&P 500 index and +13.61% for the equal-weight S&P 500 index. In 2022, the portfolio produced -15.2% vs. the S&P 500 index’s -17.96%.\nSince 2004, the Focus List portfolio has produced an annualized return of +11.69% (through October 31st, 2024). This compares to a +10.29% annualized return for the S&P 500 index and +10.12% for the equal-weight version of the index in the same time period.\nUnlock all of our powerful research, tools and analysis, including the Focus List, Zacks #1 Rank List, Equity Research Reports, Zacks Earnings ESP Filter, Premium Screener and more, as part of Zacks Premium. Gain full access now >>\nZacks ECAP Stocks Oracle & Fair Isaac Make Significant Gains\nOracle Corporation ORCL, a component of our Earnings Certain Admiral Portfolio (ECAP), has jumped 39.3% over the past 12 weeks. Fair Isaac Corporation FICO has followed Oracle with 35.6% returns.\nThe Zacks Earnings Certain Admiral Portfolio (ECAP), which consists of 30 concentrated, ultra-defensive, long-term Buy-and-Hold stocks, returned +1.97% for September 2024 vs. the S&P 500 index’s +2.14% return (IVV ETF).\nFor the year-to-date period (through the end of September 2024), the portfolio returned +20.62% vs. +22.1% for the S&P 500 index.\nIn 2023, the portfolio returned +12.17% vs. +26.28% for the S&P 500 index. The portfolio returned -4.7% in 2022 vs. the S&P 500 index’s -17.96%.\nWith little to no turnover and annual rebalance periodicity, ECAP seeks to minimize capital loss by holding shares of companies whose earnings streams exhibit a proven 20+ year track record of surviving recessionary periods with minimal impact on aggregate earnings growth relative to the overall S&P 500.\nThe ECAP and many other model portfolios are available as part of Zacks Advisor Tools, a cloud-based solution to access Zacks award-winning stock, mutual fund and ETF research. Click here to schedule a demo.\nZacks ECDP Stocks Fastenal and Home Depot Outperform Peers\nFastenal Company FAST, which is part of our Earnings Certain Dividend Portfolio (ECDP), has returned 23.1% over the past 12 weeks. Another ECDP stock, The Home Depot, Inc. HD, has also climbed 15% over the same time frame. Of course, the inclination of investors toward quality dividend stocks to secure an income stream amid heightened market volatility contributed to this performance.\nCheck Fastenal's dividend history here>>>\nCheck Home Depot’s dividend history here>>>\nWith an extremely low beta and a history of minimum earnings variability over the last 20+ years, this 25-stock portfolio helps significantly mitigate risk.\nThe Zacks Earnings Certain Dividend Portfolio (ECDP) returned +1.91% in September 2024 vs. the S&P 500 index’s +2.14% gain and the Dividend Aristocrats ETF’s (NOBL) +2.37%.\nFor the year-to-date period (through September 30th), the portfolio returned +15.85% vs. +22.1% for the S&P 500 index and +13.78% for NOBL.\nThe portfolio returned -0.9% in 2023 vs. +26.28% for the S&P 500 index and +8.11% for NOBL. The portfolio returned -2.3% in 2022 vs. -17.96% for the S&P 500 index and -8.34% for NOBL.\nClick here to access this portfolio on Zacks Advisor Tools. \nZacks Top 10 Stocks Eaton Delivers Solid Returns\nEaton Corporation plc ETN, from the Zacks Top 10 Stocks for 2024, has jumped 56.7% year to date compared to the S&P 500 Index’s +25.3% increase.\nThe Top 10 portfolio returned +43.45% this year through October 31st, vs. +20.99% for the S&P 500 index and +13.29% for the equal-weight version of the index.\nThe Top 10 portfolio returned +25.15% in 2023 vs. +26.28% for the S&P 500 index.\nSince 2012, the Top 10 portfolio has produced a cumulative return of +1,746.65% through October 31st, 2024, vs. +450.50% for the S&P 500 index. The portfolio has produced an average return of +25.5% in the period 2012 through October 31st, 2024, vs. +14.22% for the S&P 500 index and +12.49% for the equal-weight version of the index.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nFastenal Company (FAST) : Free Stock Analysis Report\nEaton Corporation, PLC (ETN) : Free Stock Analysis Report\nThe Home Depot, Inc. (HD) : Free Stock Analysis Report\nOracle Corporation (ORCL) : Free Stock Analysis Report\nFair Isaac Corporation (FICO) : Free Stock Analysis Report\nCorcept Therapeutics Incorporated (CORT) : Free Stock Analysis Report\nAxon Enterprise, Inc (AXON) : Free Stock Analysis Report\nVertex, Inc. (VERX) : Free Stock Analysis Report\nPalantir Technologies Inc. (PLTR) : Free Stock Analysis Report\nGorilla Technology Group Inc. (GRRR) : Free Stock Analysis Report\nAmerican Healthcare REIT, Inc. (AHR) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486538038"}